ZSCAN20 has been associated with atrial tachyarrhythmia and angiosarcoma, whereas ZKSCAN5 is a poor prognostic factor of breast cancer; yet, both cancer types are not associated with the syndrome [16,65]. Here, ZSCAN20 is linked to breast carcinoma.